U.S. Luxury Stock News

To the annoyance of some shareholders, Niagen Bioscience, Inc. ( NASDAQ:NAGE ) shares are down a considerable 25% in...

It's easy to match the overall market return by buying an index fund. Active investors aim to buy stocks that vastly...

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...

With the business potentially at an important milestone, we thought we'd take a closer look at XOMA Royalty...

In late September 2025, Enanta Pharmaceuticals announced positive topline results from its Phase 2b trial of zelicapavir for treating respiratory syncytial virus (RSV) in high-risk adults, observing faster symptom resolution and a lower hospitalization rate despite not meeting the trial's primary endpoint. This proof-of-concept success provides the company with clear support to advance zelicapavir into Phase 3 development, potentially addressing significant unmet needs in the RSV market for...

Soft earnings didn't appear to concern H.B. Fuller Company's ( NYSE:FUL ) shareholders over the last week. Our analysis...

Key Insights Significantly high institutional ownership implies Adverum Biotechnologies' stock price is sensitive to...

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...

Nature Wood Group Limited ( NASDAQ:NWGL ) shareholders have had their patience rewarded with a 36% share price jump in...

While XPEL, Inc. ( NASDAQ:XPEL ) might not have the largest market cap around , it saw significant share price movement...

Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...

Key Insights Institutions' substantial holdings in NN implies that they have significant influence over the company's...

The market seemed underwhelmed by last week's earnings announcement from Accenture plc ( NYSE:ACN ) despite the healthy...

Hongli Group (NasdaqCM:HLP) has just swung to profitability, a notable shift given its challenging track record. Over the last five years, the company’s earnings have declined sharply at an average rate of 49.9% per year, and despite this new profit milestone, the historical headwinds remain evident for investors assessing future growth prospects. See our full analysis for Hongli Group. The next section looks beyond the numbers, putting Hongli Group’s latest results in the context of how...

If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...

There wouldn't be many who think Brady Corporation's ( NYSE:BRC ) price-to-earnings (or "P/E") ratio of 19.5x is worth...

CEVA, Inc. ( NASDAQ:CEVA ) shareholders would be excited to see that the share price has had a great month, posting a...

Key Insights Using the 2 Stage Free Cash Flow to Equity, Griffon fair value estimate is US$115 Griffon's US$77.54 share...

In September 2025, the ADP National Employment Report revealed an unexpected loss of 32,000 private-sector jobs, marking the weakest monthly showing since March 2023 and highlighting significant losses in leisure and hospitality. This surprise downturn in the labor market has fueled expectations for a Federal Reserve rate cut, prompting increased investor interest in gold as a traditional safe haven. We'll explore how speculation of lower interest rates could shape SPDR Gold Trust's...

Bitcoin Depot Inc. recently announced guidance projecting approximately US$160 million in revenue for the third quarter of 2025, reflecting an anticipated 18% increase over the prior year’s period. The company was also added to the S&P Global BMI Index in late September, marking a milestone that elevates its profile among institutional investors. We’ll explore how Bitcoin Depot’s projected revenue growth and index inclusion shape its investment narrative amid rising investor attention. These...

Evolent Health (EVH) shares have been on a rough slide lately, giving investors plenty to talk about. With the stock down nearly 18% over the past month, many are re-examining its recent performance and outlook. See our latest analysis for Evolent Health. After a difficult month, Evolent Health's recent 30-day share price return of -18% has certainly caught investors' attention. Looking at a broader timeframe, momentum has cooled with a one-year total shareholder return of -69%, reflecting...

In late September 2025, Prospect Capital’s CEO John F. Barry and COO Grier Eliasek made substantial purchases of company stock, with Barry acquiring 925,000 shares and Eliasek 370,000 shares, soon after the company completed an $18 million investment in a physician-led addiction treatment facility called The Ridge. This wave of insider buying came as the company discussed mixed quarterly earnings and emphasized strong net investment income and portfolio repositioning efforts. We'll look at...

Buckle's (NYSE:BKE) stock is up by a considerable 21% over the past three months. As most would know, fundamentals are...

Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...